biosig_rgb.png
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI
01 nov. 2023 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
Stereotaxis Logo - New Tagline - Black Text.png
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
31 oct. 2023 08h57 HE | Stereotaxis, Inc.
Stereotaxis (NYSE: STXS) & Abbott (NYSE:ABT) announce the first patients in the US have been treated successfully utilizing combined technologies
22157.jpg
Global Cardiac Ablation Device Market Set for Remarkable Growth, Fueled by Rising Demand for Minimally Invasive Procedures and Technological Advancements
30 oct. 2023 08h13 HE | Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Cardiac Ablation Devices Market" report has been added to ResearchAndMarkets.com's offering. Rising incidents of cardiac arrhythmia and the...
Global Implanted Defibrillator Market
Implantable Defibrillators Global Market Research Report 2023: Growth Fueled by Rising Sudden Cardiac Arrest Cases - Long-term Forecast to 2027 and 2032
24 oct. 2023 05h10 HE | Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Implantable Defibrillators Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global implanted defibrillator...
22157.jpg
The Rise of Pulsed Field Ablation: A Safer, Minimally Invasive Solution for Atrial Fibrillation and Cardiac Arrhythmias
18 oct. 2023 06h28 HE | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
04 oct. 2023 08h49 HE | Stereotaxis, Inc.
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Electrophysiology Ablation Market Grows Strong, Aiming for US$ 7.9 Billion by 2033 | Persistence Market Research
28 sept. 2023 06h03 HE | Persistence Market Research
New York, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The electrophysiological ablation market is expected to generate US$ 3.1 billion in revenue globally in 2022 and grow at a CAGR of 8.8% to US$ 7.9...
Stereotaxis Logo - New Tagline - Black Text.png
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
06 sept. 2023 08h56 HE | Stereotaxis, Inc.
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
biosig_rgb.png
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
24 août 2023 10h30 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
23 août 2023 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 23, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...